Added to YB: 2021-08-31
Pitch date: 2021-08-31
BNTX:US [bullish]
BioNTech SE
-66.64%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
Market Cap
$22.7B
Pitch Price
$331.04
Price Target
N/A
Dividend
N/A
EV/EBITDA
-19.94
P/E
-37.94
EV/Sales
2.67
Sector
Biotechnology
Category
N/A
Show full summary:
BioNTech SE Sponsored ADR BNTX:US
A summary for this pitch has not been created yet.
Read full article (0 min)